Stockchase Opinions

David Burrows Irhythm Technologies IRTC-O BUY Apr 18, 2018

They make a skin patch to monitor for irregular heartbeats then indicates on an app whether there are heart issues. Patient incomes are 3x as good as the next-best technology. This captures only 6% of the U.S. market and not international yet. IRTC did not break down during the recent correection. Strong.

N/A

Stock price when the opinion was issued

0
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK

This is technology to monitor heart rhythm heart rates. It created a wireless patch that gives 50% better data than other technology. They only have 5% of the market share in the US today and he expects it to grow by 50% per year for several years. Yield 0%. (Analysts’ price target is $71.60 )

COMMENT

He has owned IRTC-O in the past. It is in the medical device space and has equipment that looks for heart arrhythmia and loads the data to the cloud. The market has not yet said this stock has taken a positive turn yet. Earnings are growing and it is growing into its share price. He wants to see it break above $85-$87 before getting back in. He would prefer holding EW-N

BUY
It is a great theme – medical devices. It is a company that makes bio-sensors that connect wirelessly to the cloud to report a patient's condition. They use artificial intelligence to recognize when you may be getting into difficulty. It has had a great run recently. The markets they are playing into are giant. These technologies are being accelerated. They are in the center of the space and could be involved in testing and monitoring for COVID, ultimately.